Mobile Stroke Units: Current Evidence and Impact
- 1 January 2022
- journal article
- review article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 22 (1) , 71-81
Abstract
Purpose of Review Several approaches have been developed to optimize prehospital systems for acute stroke given poor access and significant delays to timely treatment. Specially equipped ambulances that directly initiate treatment, known as Mobile Stroke Units (MSUs), have rapidly proliferated across the world. This review provides a comprehensive summary on the efficacy of MSUs in acute stroke, its various applications beyond thrombolysis, as well as the establishment, optimal setting and cost-effectiveness of incorporating an MSU into healthcare systems. Recent Findings MSUs speed stroke treatment into the first “golden hour” when better outcomes from thrombolysis are achieved. While evidence for the positive impact of MSUs on outcomes was previously unavailable, two recent landmark controlled trials, B_PROUD and BEST-MSU, show that MSUs result in significantly lesser disability compared to conventional ambulance care. Summary of Review Emerging literature prove the significant impact of MSUs. Adaptability however remains limited by significant upfront financial investment, challenges with reimbursements and pending evidence on their cost-effectiveness.Keywords
This publication has 78 references indexed in Scilit:
- Development and Validation of a Dispatcher Identification Algorithm for Stroke EmergenciesStroke, 2012
- Review of Portable CT with Assessment of a Dedicated Head CT ScannerAmerican Journal of Neuroradiology, 2009
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeNew England Journal of Medicine, 2008
- Time Is Brain—QuantifiedStroke, 2006
- The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrumentThe Lancet Neurology, 2005
- “Mobile Stroke Unit” for Hyperacute Stroke TreatmentStroke, 2003
- Comparable Studies of the Incidence of Stroke and its Pathological TypesStroke, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality.Stroke, 1993
- Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project.Stroke, 1993